PremiumCompany AnnouncementsGenscript Biotech Updates Nomination Committee Terms to Enhance Governance Legend Biotech to Present New CARVYKTI Data at 2025 ASCO and EHA Meetings GenScript Announces Legend Biotech’s Q1 2025 Financial Results PremiumCompany AnnouncementsGenscript Biotech Releases Supplemental Announcement on Legend Biotech’s Financial Results Genscript Biotech Reports Strong Profit Surge in 2024 Genscript Biotech Reports Significant Profit Boost from Cell Therapy Deconsolidation PremiumCompany AnnouncementsGenscript Biotech Reports Substantial Profit Growth in 2024 Genscript Biotech Strengthens Governance with New Committee Genscript Biotech Enhances Risk Management with New Sub-Committee